NCT04914897 2025-10-02A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)SanofiPhase 2 Terminated106 enrolled 21 charts